DSC05688(1920X600)

Tawagar jami'ar Shanghai Tongji ta zo ziyarar Yonker

A ranar 16 ga Disamba, 2020, furofesoshi daga Jami'ar Shanghai Tongji sun jagoranci tawagar kwararru don ziyartar kamfaninmu. Mr. Zhao Xuecheng, babban manajan Yonker Medical, da Mr. Qiu Zhaohao, manajan sashen R&D sun sami kyakkyawar maraba, kuma sun jagoranci dukkan shugabannin da suka ziyarci cibiyar tallata magunguna ta Yonker.

1

Manufar wannan ziyarar ita ce fahimtar tarihin ci gaba da halin yanzu na kamfaninmu, ƙarfafa hulɗar da kamfaninmu, da kuma shirya don ƙarin musayar fasaha da haɗin gwiwa a nan gaba.

2

Da farko dai, tawagar ƙwararrun ta lura da kuma sauraron taƙaitaccen gabatarwar kamfaninmu na PPT da bayani a ɗakin taron. A lokacin, masana daga jami'ar Tongji sun yi tambayoyi da yawa, kamar dabarun kasuwanci na kamfanin, nau'in fasahar da aka yi amfani da su, da tsarin zuba jari a manyan fasahohin zamani da sabbin fasahohi, yadda za a inganta yadda ake samar da kayayyaki, da kasada da damar da kasuwancin ke fuskanta, da dai sauransu. Mr.

3

Sa'an nan, a karkashin jagorancin Mr. Zhao shugaban kamfanin Yonker Medical, tawagar kwararru sun ziyarci cibiyar samar da kayayyakin. Bayan koyo game da ƙarfin samar da kamfaninmu da ƙarfin gwaji, shugabannin Jami'ar Tongji sun tabbatar da R&D na kamfaninmu, ƙwarewar gwaji da samarwa, kuma sun sanya tsammanin a kansu, suna fatan Yonker Medical zai yi ƙoƙari na musamman don ƙarfafa ƙirƙira mai zaman kanta da fasahar R&D don ta ci gaba da shawo kan sabbin ƙalubalen matsalolin kiwon lafiya da na kiwon lafiya a nan gaba!

4
5

A karshe, Mr. Zhao shugaban kamfanin Yonker Medical ya bayyana cewa, kamfanin zai gudanar da zurfafa bincike kan sabbin ayyukan R&D masu alaka da masana masu ziyara don neman karin damar yin hadin gwiwa.

6

Bayan haka, kamfaninmu zai ci gaba da ƙarfafa haɗin gwiwa da haɗin gwiwa tare da ƙwararrun kwalejoji da jami'o'i, samar da ƙarin dama don koyo, yin amfani da sabbin dabaru da fasahar ci gaba na kwalejoji da jami'o'i, da kuma yin isassun shirye-shirye don ci gaban kamfanin a nan gaba.

7

Lokacin aikawa: Dec-06-2020

samfurori masu dangantaka